Patten Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Patten Group’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-67	Closed	-$4.06K	–	660
2016 Q1	$4.06K	Hold	67	–	–	﹤0.01%	555
2015 Q4	$4.73K	Buy	67 +3	+5%	+$213	﹤0.01%	570
2015 Q3	$4.26K	Hold	64	–	–	﹤0.01%	509
2015 Q2	$5.03K	Buy	+64	New	+$4.98K	﹤0.01%	508

Other funds holding PJP

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

MWM

Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return

Patten Group's PJP Position: Q2 2016 in Review

Patten Group sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2016, closing a stake of 67 shares — an estimated $4.06K sold.

Patten Group first reported a position in PJP in Q2 2015 and held it in 4 quarters. The position peaked at $5.03K in Q2 2015. 97 funds tracked by Wall St. Rank hold PJP as of Q2 2016.

Patten Group reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2016 after selling out during the quarter.
Patten Group sold 67 Invesco Pharmaceuticals ETF shares in Q2 2016, an estimated $4.06K.
Patten Group first reported a position in Invesco Pharmaceuticals ETF in Q2 2015 and held it in 4 quarters.
Patten Group's Invesco Pharmaceuticals ETF position peaked at $5.03K in Q2 2015.
97 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2016.

Based on Patten Group's 13F filing for Q2 2016, filed 15 Aug 2016.